Piramal Pharma appoints Vibha Paul Rishi to its Board of Directors
Rishi is a marketing professional and has held global leadership positions across branding, strategy, innovation and human capital
Industrial talks | 30/09/2022 | By Sudeep Soparkar | 1116
Jiuzhou Pharma to buy Sandoz finished drugs plant in Zhongshan for $15.1 M
The Chinese firm also plans to refurbish and expand the facility, altogether redirecting $18.5 million of capital to the Sandoz project.<br />
Industrial talks | 29/09/2022 | By Sudeep Soparkar | 1028
Biopharmaceutical company Ipsen unveils 52 M Euro expansion plan
The investment is aimed at boosting medicine and ingredient production in cancer and rare disease space
Industrial talks | 28/09/2022 | By Sudeep Soparkar | 848
OPPI appoints Suresh Pattathil as president
Suresh Pattathil succeeds S Sridhar who has been the President of OPPI since February 2021
Industrial talks | 27/09/2022 | By Sudeep Soparkar | 885
Sekhmet Pharmaventures buys stake in Hyd-based Optimus Group
Optimus, a manufacturer of pharmaceutical goods with vertical integration that includes advanced intermediates, active pharmaceutical ingredients etc
Industrial talks | 27/09/2022 | By Sudeep Soparkar | 2269
IQVIA Market Reflection Report - JB Pharma
IQVIA Market Reflection Report pins JB Pharma as the fastest growing Pharma Company with a growth rate of over 20% for the month of August 2022
Industrial talks | 22/09/2022 | By Sudeep Soparkar | 1195
Mankind Pharma files DRHP with SEBI
The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1
Industrial talks | 19/09/2022 | By Sudeep Soparkar | 837
Ami Lifesciences appoints Amit Kaptain as CEO
Kaptain will be responsible for building business strategy and longstanding global partnerships<br />
Industrial talks | 16/09/2022 | By Sudeep Soparkar | 664
DFE Pharma opens Center of Excellence in Hyderabad
The centre will provide fast-track medicines formulation<br />
Industrial talks | 13/09/2022 | By Sudeep Soparkar | 695
Mumbai-based Blue Jet Healthcare files for IPO
The public issue with a face value of Rs 2 per equity share is a complete offer-for-sale (OFS) of up to 21,683,178 equity shares by Promoter and selling shareholders
Industrial talks | 05/09/2022 | By Sudeep Soparkar | 905
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy